Diabetes drug showdown: which combo sheds more pounds?
NCT ID NCT07247656
First seen Jan 10, 2026 · Last updated Jun 18, 2026 · Updated 29 times
Summary
This study tested two different diabetes pill combinations to see which helped people with type 2 diabetes lose more weight. 200 adults aged 40-70 with high blood sugar and a BMI of 25 or more took part. The trial compared empagliflozin plus linagliptin against empagliflozin plus metformin over 12 weeks, measuring changes in weight, blood sugar, and waist size.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bahria University
Karachi, Sindh, Pakistan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.